Min­neso­ta judge nar­rows charges in class ac­tion suit against My­lan, phar­ma­cy ben­e­fit man­agers over EpiPen price hikes

Sec­ond time’s the charm for Vi­a­tris and a suite of phar­ma­cy ben­e­fit man­agers in a pro­posed class-ac­tion law­suit al­leg­ing col­lu­sion over price hikes for the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.